VISIONPLATFORMABOUTGET IN TOUCH

Genomics
to the Power
of Every Person

What if...

What if tracking genetic and epigenetic markers was as simple as taking your temperature?

What if disease markers could be detected anywhere, by anyone, within minutes, without the need to send samples to central labs and wait weeks for results?

What if the genomic insights needed to protect crops, monitor ecosystems, and ensure food security were available in real time, anywhere in the world?

Discover Acorn

The Power of Precision Genomics—Unlocked for Everyone

Discover Acorn

The precision genomics platform built for decentralized, affordable, and automated nanopore genome sequencing at scale.

Our Unique Approach

Solid State Nanopore Gene Sequencing

01  /  Integrated Sequencing Chip
02  /  High-Speed DNA Translocation
03  /  Superior Mechanical & Chemical Stability
04  /  Increased Sensitivity
EASE
Simplicity & Speed
POWER
Comprehensiveness & Precision
LOW COST
Opportunity & Scalability

Speed and Ease for Advantage and Scalability

Acorn genetics
2nd gen
3rd gen
protein nanopore
Long Read Capabilities
10K or Less Cost to Purchase
/
Intuitive, User-Friendly Design
Rapid Turnaround on Results
Durable, Reusable Flow Cell

For People...

Plants...

Pathogens...

... and everything else.

Our Team

World-Class Innovators in 3rd Gen Sequencing

Ana Cornell,
Chief Executive Officer
Thiel Fellowship
Northwestern University
Field Museum
Ryan Abbott,
Chief Technology Officer
Simpson Querrey Institute

Rogers Research Group
Brian Fritz, PhD,
Chief Commercial Officer
Oxford Nanopore
10X Genomics
Illumina
Kevin Travers, PhD,
Chief Scientific Officer
LevitasBio
Roche Sequencing
Pacific Biosciences
Max Derbyshire,
Chief Operating Officer
Northwestern Medicine

Leadership Initiatives
Kristin Gleitsman, PhD,
Advisor
Veracyte
Guardant Health
Pacific Biosciences
MyPhuong Le, PhD,
Advisor
Aquillius & Aquillius Ventures
University of Colorado
Microtek
Our Team
Ross Wojcik
Product
Jake Turner, MS
Engineering
Aakaanksha Maddineni, MS
Biology

Supported by Leading Investors